■中国乳腺外科学会(CSBrS)2021年实践指南发布近一年前。根据先前出版物的综合反馈对新指南进行了修订。旨在为中国乳腺外科医师提供更好的参考。
■参考等级(建议评估等级,开发和评估)系统,准则接受的证据分为四类:I,II,III和IV,定量地反映了证据的可靠性。该指南还综合考虑了指南在中国临床实践中的可及性,并给出了不同优势的建议。
■该指南强调了治愈性手术方法属于根治性肿瘤手术的基本思想。六章,包括“浸润性乳腺癌患者的诊断和治疗”,“早期乳腺癌患者的前哨淋巴结活检”,“早期乳腺癌患者的保乳手术”,“乳腺癌改良根治术”,“乳腺癌全身治疗的中心静脉通路”,和“妊娠期乳腺癌和产后乳腺癌”进行了修订。
■与2021版相比,根据最新的研究证据和临床需求,新指南已分为六章进行了修订。
UNASSIGNED: The Chinese Society of Breast Surgery (CSBrS) Practice
Guideline 2021 was published nearly one year ago. The new
guideline was revised based on comprehensive feedback of the previous publication. The aim is to provide a better reference suitable for Chinese breast surgeons.
UNASSIGNED: Referred to GRADE (Grading of Recommendations Assessment, Development and Evaluation) system, evidences accepted by the
Guideline were classified into four categories: I, II, III and IV, which reflected the reliability of the evidences quantitatively. The
guideline also comprehensively considered the accessibility of the
guideline in clinical practice in China and gave recommendations with different strengths.
UNASSIGNED: The
guideline emphasized the basic idea that a curative surgical approach falls under the category of radical tumor surgery. Six chapters, including \"Diagnosis and treatment of patients with invasive breast cancer\", \"Sentinel lymph node biopsy in patients with early-stage breast cancer\", \"Breast-conserving surgery in patients with early-stage breast cancer\", \"Modified radical mastectomy of breast cancer\", \"Central venous access for the systemic treatment of breast cancer\", and \"Breast cancer in pregnancy and postpartum breast cancer\" were revised.
UNASSIGNED: Compared with the 2021 edition, the new guideline has been revised in six chapters based on the latest research evidence and clinical needs.